According to Gram Research analysis, the ratio of LDL cholesterol to HDL cholesterol (LDL-C/HDL-C) is significantly higher in people with Helicobacter pylori infection and can predict infection risk with 71% accuracy in people without diabetes. A 2026 cross-sectional study of 400 participants found that an LDL-C/HDL-C ratio above 2.24 correctly identified 79% of people with H. pylori infection, suggesting this simple blood measurement could help doctors identify who is at risk for this common stomach infection before it causes serious complications like ulcers or cancer.
Researchers discovered that a specific cholesterol measurement called LDL-C/HDL-C ratio may help identify who is at risk for Helicobacter pylori infection, a common stomach bacteria linked to ulcers and cancer. In a study of 400 people without diabetes, those infected with H. pylori had different cholesterol patterns than uninfected people. The LDL-C/HDL-C ratio was the strongest predictor, suggesting doctors could use this simple blood test measurement to spot infection risk. This finding opens new possibilities for preventing serious stomach problems through diet and lifestyle changes before infection causes damage.
Key Statistics
A 2026 cross-sectional study of 400 participants found that the LDL-C/HDL-C ratio predicted Helicobacter pylori infection with 71% accuracy, with an optimal cutoff value of 2.24 showing 79% sensitivity and 57% specificity.
Among 400 people without diabetes, those with Helicobacter pylori infection had significantly higher LDL-C/HDL-C ratios compared to uninfected individuals, with the ratio showing a nonlinear association with infection risk.
In a 2026 analysis of 400 participants, the LDL-C/HDL-C ratio was the strongest independent predictor of Helicobacter pylori infection among eight different cholesterol ratios examined, with a receiver operating characteristic area under the curve of 0.713.
The Quick Take
- What they studied: Whether certain cholesterol measurements in your blood can predict if you have or are at risk for Helicobacter pylori infection, a common stomach bacteria.
- Who participated: 400 people without diabetes who had a breath test to check for H. pylori infection. Of these, 75 had the infection and 325 did not.
- Key finding: The ratio of LDL cholesterol to HDL cholesterol (LDL-C/HDL-C) was significantly higher in people with H. pylori infection and could predict infection risk with 79% accuracy when using a cutoff value of 2.24.
- What it means for you: A simple blood test measuring your cholesterol ratio might help doctors identify if you’re at risk for H. pylori infection before it causes serious problems like ulcers or stomach cancer. However, this is early research and needs larger studies to confirm the finding applies to everyone.
The Research Details
This was a cross-sectional study, which means researchers looked at a group of people at one point in time rather than following them over years. Participants without diabetes came to the clinic and had their blood tested for cholesterol levels and other markers. They also took a breath test (the 13C-urea breath test) to check if they had H. pylori infection. Researchers then calculated eight different cholesterol ratios from the blood results and compared these numbers between people with and without the infection.
The researchers used statistical methods to find which cholesterol ratio was most strongly connected to H. pylori infection. They tested whether the relationship was linear (a straight line) or curved (nonlinear), meaning the effect might be stronger at certain levels. They also checked how well each ratio could predict who had the infection by calculating sensitivity (how many infected people it correctly identified) and specificity (how many uninfected people it correctly identified).
This approach allowed researchers to identify practical biomarkers, or measurable signs, that could help doctors assess infection risk in everyday clinical practice without expensive or invasive testing.
Understanding which blood markers predict H. pylori infection is important because the infection is extremely common worldwide and causes serious health problems including ulcers, chronic inflammation, and stomach cancer. Most previous research only looked at overall cholesterol changes without examining specific ratios. By identifying that the LDL-C/HDL-C ratio is particularly predictive, this study provides a practical tool using standard blood tests that doctors already order. This could help identify at-risk people early so they can receive treatment or make preventive lifestyle changes before complications develop.
This study has several strengths: it used a validated breath test to confirm H. pylori status, analyzed multiple cholesterol ratios to find the strongest predictor, and used appropriate statistical methods including sensitivity analyses to check if findings were stable. However, the study is cross-sectional, meaning it shows association but cannot prove that cholesterol ratios cause H. pylori infection or vice versa. The sample size of 400 is moderate, and all participants were from a single clinic, so results may not apply to different populations. The researchers excluded people with diabetes, so findings may not apply to diabetic patients. The authors acknowledge that larger prospective studies are needed to confirm causality and test whether these findings work across different groups of people.
What the Results Show
Among the 400 participants, 75 had H. pylori infection and 325 did not. People with H. pylori infection had significantly higher levels of several blood markers including white blood cells (neutrophils), blood sugar (fasting plasma glucose), uric acid, triglycerides, and LDL cholesterol. They also had lower HDL cholesterol, the protective type. When researchers examined eight different cholesterol ratios, the LDL-C/HDL-C ratio showed the strongest independent association with H. pylori infection.
Using a cutoff value of 2.24 for the LDL-C/HDL-C ratio, the test correctly identified 79% of people with H. pylori infection (sensitivity) and correctly identified 57% of people without infection (specificity). The overall accuracy of this ratio for predicting infection was 71%, which is considered moderate to good for a screening tool. Importantly, the relationship between LDL-C/HDL-C ratio and H. pylori infection was nonlinear, meaning the effect was not a simple straight line but rather curved, suggesting the relationship is more complex at different ratio levels.
The researchers also found that this LDL-C/HDL-C ratio remained a strong predictor even after accounting for other factors like age, sex, and other blood markers, indicating it provides independent information about infection risk.
Other cholesterol ratios examined in the study showed weaker associations with H. pylori infection compared to LDL-C/HDL-C. The triglyceride/HDL-C ratio and non-HDL-C/HDL-C ratio also showed some association with infection, but neither was as strong as LDL-C/HDL-C. The study found that people with H. pylori infection had higher triglycerides and lower HDL cholesterol overall, confirming previous research showing that the infection is associated with unfavorable lipid patterns. These secondary findings suggest that H. pylori infection may affect cholesterol metabolism in multiple ways, but the LDL-C/HDL-C ratio captures the most predictive information.
This research builds on previous studies showing that H. pylori infection is linked to abnormal cholesterol levels and dyslipidemia, a condition of unhealthy cholesterol patterns. However, most earlier studies only reported overall cholesterol changes without detailed analysis of specific ratios. This study advances the field by identifying that the LDL-C/HDL-C ratio is particularly important and could serve as a practical biomarker. The finding that the relationship is nonlinear is also novel and suggests that previous linear analyses may have missed important details about how cholesterol ratios relate to infection risk. The moderate predictive accuracy (71%) is consistent with other biomarker studies for infectious diseases and suggests this ratio could be useful as part of a broader assessment strategy rather than as a standalone diagnostic test.
This study has important limitations that readers should understand. First, it is cross-sectional, showing only that cholesterol ratios and H. pylori infection occur together, not that one causes the other. Second, all participants came from a single clinic, so results may not apply to different populations with different genetic backgrounds or lifestyles. Third, the study excluded people with diabetes, so findings cannot be applied to diabetic patients. Fourth, the sample size of 400 is moderate, and larger studies would provide more reliable estimates. Fifth, the study did not examine whether treating H. pylori infection changes cholesterol ratios, which would help establish whether the relationship is causal. Finally, the specificity of 57% means that more than 40% of uninfected people would have a high LDL-C/HDL-C ratio, limiting its usefulness as a standalone screening tool.
The Bottom Line
Based on this research, the LDL-C/HDL-C ratio may be useful as one factor among several in assessing H. pylori infection risk, particularly in people without diabetes. However, this should not replace the standard breath test or other diagnostic methods for confirming infection. If you have a high LDL-C/HDL-C ratio (above 2.24), discuss with your doctor whether H. pylori testing is appropriate, especially if you have symptoms like stomach pain or a family history of stomach cancer. Confidence in this recommendation is moderate because the study is cross-sectional and needs confirmation in larger prospective studies.
This finding is most relevant for people without diabetes who want to understand their H. pylori infection risk. Healthcare providers may find this useful for risk stratification, particularly in populations where H. pylori is common. People with a family history of stomach cancer or those experiencing chronic stomach symptoms should especially discuss H. pylori testing with their doctor. This research may be less applicable to people with diabetes, as they were excluded from the study. People already diagnosed with H. pylori infection should focus on treatment rather than using this ratio for diagnosis.
If you have a high LDL-C/HDL-C ratio and test positive for H. pylori, treatment typically involves antibiotics and acid-reducing medications taken for 1 to 2 weeks. Improvement in stomach symptoms usually occurs within days to weeks of starting treatment. However, cholesterol ratios typically take several weeks to months to improve with diet and lifestyle changes alone. If you make dietary changes to lower your LDL-C/HDL-C ratio, expect to see measurable improvements in your next blood test in 4 to 8 weeks.
Frequently Asked Questions
What is the LDL-C/HDL-C ratio and why does it matter for H. pylori infection?
The LDL-C/HDL-C ratio divides your LDL cholesterol (the harmful type) by your HDL cholesterol (the protective type). Research shows this ratio is significantly higher in people with H. pylori infection and can predict infection risk with 71% accuracy, making it a practical screening tool.
Can I use my cholesterol ratio to diagnose H. pylori infection instead of a breath test?
No, the cholesterol ratio should not replace standard H. pylori tests like the breath test. While the ratio can identify people at higher risk, it is not accurate enough for diagnosis alone. Use it as one factor to discuss with your doctor whether testing is appropriate.
If my LDL-C/HDL-C ratio is high, does that mean I definitely have H. pylori?
Not necessarily. A high ratio means your risk is elevated, but 43% of uninfected people also have ratios above the cutoff value. A high ratio should prompt discussion with your doctor about H. pylori testing, but only a breath test or other diagnostic method can confirm infection.
How can I lower my LDL-C/HDL-C ratio to reduce H. pylori infection risk?
Eat more fiber, reduce saturated fats, increase plant-based foods, and limit processed foods to lower LDL and raise HDL cholesterol. These dietary changes typically improve your ratio within 4 to 8 weeks. Regular exercise and maintaining a healthy weight also help.
Does this research apply to people with diabetes?
This study excluded people with diabetes, so the findings may not apply to diabetic patients. If you have diabetes and want to understand your H. pylori risk, discuss with your doctor whether these findings are relevant to your situation.
Want to Apply This Research?
- Track your LDL-C/HDL-C ratio quarterly by recording your LDL cholesterol and HDL cholesterol values from blood tests, then calculate the ratio (LDL divided by HDL). Note any H. pylori testing results and dates. Monitor whether the ratio changes after dietary modifications or H. pylori treatment.
- If your LDL-C/HDL-C ratio is elevated, use the app to log dietary changes that improve cholesterol: increasing fiber intake, reducing saturated fats, adding more plant-based foods, and limiting processed foods. Set reminders to schedule H. pylori testing if recommended by your doctor. Track any stomach symptoms to discuss with your healthcare provider.
- Set up quarterly reminders to review your cholesterol values from blood tests and calculate your LDL-C/HDL-C ratio. Create a trend chart showing how your ratio changes over time. If you receive H. pylori treatment, track symptom improvement and retest 4 weeks after completing antibiotics to confirm eradication. Log any dietary or lifestyle changes and correlate them with ratio improvements.
This article summarizes research findings and should not be used for self-diagnosis or to replace professional medical advice. The LDL-C/HDL-C ratio is not a diagnostic test for Helicobacter pylori infection. If you suspect you have H. pylori infection or experience persistent stomach symptoms, consult a healthcare provider for appropriate testing and treatment. This study was cross-sectional and cannot prove causality. Results may not apply to all populations, particularly those with diabetes or different ethnic backgrounds. Always discuss any health concerns and test results with your doctor before making medical decisions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.